Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Sae Kitano

6PUBLICATIONS
28CO-AUTHORS
Artificial life and complex adaptive systemsPredictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

Sort by Publication Date:
|May 20, 2026
Comparative evaluation of treatment recommendations generated by generative AI and breast cancer specialists for advanced and recurrent breast cancer: a multidimensional assessment of evidence interpretation and clinical decision support.

|Apr 01, 2026
Integration of gene expression profiling and mutation analysis via RNA sequencing: transitioning the 95-gene classifier to a next-generation platform in early-stage HR+/HER2- breast cancer.

Chikage Kato, Yoshiaki Sota, Sae Kitano

|Sep 25, 2025
Pathological homogeneity and utility in the genetic diagnosis of paired mirror samples from breast cancer 10G-vacuum-assisted biopsies using a novel longitudinal dividing device.

Akira Watanabe, Sae Kitano, Chikage Kato

|Jun 25, 2025
Validation of the predictive ability for recurrence and the clinical utility of the 95-gene classifier (95GC) through an integrated analysis of five studies.

Aya Imai, Ryo Tsunashima, Yu Hidaka

|Jun 11, 2024
Validation of late recurrence prediction by gene expression profiles and clinicopathological factors in estrogen receptor-positive breast cancer.

Sae Kitano, Ryo Tsunashima, Chikage Kato

|Apr 08, 2024
Investigation of recurrence prediction ability of EndoPredict<sup>®</sup> using microarray data from fresh frozen tissues in ER-positive, HER2-negative breast cancer and indication expansion of EndoPredict<sup>®</sup> from microarray data from fresh-frozen to FFPE tissues.

Akira Watanabe, Ryo Tsunashima, Chikage Kato

Pageof 1

Frequent Collaborators

6 joint publications

Akira Watanabe

6 joint publications

Midori Morita

6 joint publications

Yasuto Naoi

5 joint publications

Yoshiaki Sota

4 joint publications

Ryo Tsunashima

3 joint publications

Chikage Kato

2 joint publications

Koichi Sakaguchi

2 joint publications

Kenzo Shimazu

1 joint publications

Yu Hidaka

1 joint publications

Masahiko Suzuki

Frequent Collaborators

6 joint publications

Akira Watanabe

6 joint publications

Midori Morita

6 joint publications

Yasuto Naoi

5 joint publications

Yoshiaki Sota